What is the intrinsic value of OTLK?
As of 2025-07-04, the Intrinsic Value of Outlook Therapeutics Inc (OTLK) is
2.45 USD. This OTLK valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.78 USD, the upside of Outlook Therapeutics Inc is
37.90%.
Is OTLK undervalued or overvalued?
Based on its market price of 1.78 USD and our intrinsic valuation, Outlook Therapeutics Inc (OTLK) is undervalued by 37.90%.
OTLK Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
2.45 - 2.45 |
2.45 |
37.90% |
| P/E |
7.80 - 14.19 |
10.62 |
496.4% |
| DDM - Stable |
3.27 - 7.21 |
5.24 |
194.6% |
| DDM - Multi |
(11.63) - (20.92) |
(15.04) |
-945.0% |
OTLK Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
75.10 |
| Beta |
0.78 |
| Outstanding shares (mil) |
42.19 |
| Enterprise Value (mil) |
100.59 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.81% |
| Cost of Debt |
5.00% |
| WACC |
7.67% |